Autonomix Medical, Common Stock Beta
| AMIX Stock | 3.35 0.18 5.10% |
Autonomix Medical, Common fundamentals help investors to digest information that contributes to Autonomix Medical,'s financial success or failures. It also enables traders to predict the movement of Autonomix Stock. The fundamental analysis module provides a way to measure Autonomix Medical,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Autonomix Medical, stock.
Autonomix |
Autonomix Medical, Common Company Beta Analysis
Autonomix Medical,'s Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Autonomix Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Autonomix Medical, is extremely important. It helps to project a fair market value of Autonomix Stock properly, considering its historical fundamentals such as Beta. Since Autonomix Medical,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Autonomix Medical,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Autonomix Medical,'s interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Autonomix Medical, Common has a Beta of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The beta for all United States stocks is 100.0% lower than that of the firm.
Autonomix Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Autonomix Medical,'s direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Autonomix Medical, could also be used in its relative valuation, which is a method of valuing Autonomix Medical, by comparing valuation metrics of similar companies.Autonomix Medical, is currently under evaluation in beta category among its peers.
Autonomix Fundamentals
| Return On Equity | -270.17 | ||||
| Return On Asset | -1.76 | ||||
| Current Valuation | 2.17 M | ||||
| Shares Outstanding | 1.77 M | ||||
| Shares Owned By Insiders | 27.20 % | ||||
| Shares Owned By Institutions | 8.67 % | ||||
| Number Of Shares Shorted | 36.62 K | ||||
| Price To Book | 1.96 X | ||||
| EBITDA | (15.27 M) | ||||
| Net Income | (15.43 M) | ||||
| Total Debt | 1 M | ||||
| Book Value Per Share | 3.21 X | ||||
| Cash Flow From Operations | (6.65 M) | ||||
| Short Ratio | 0.06 X | ||||
| Earnings Per Share | (19.74) X | ||||
| Target Price | 28.0 | ||||
| Market Capitalization | 6.24 M | ||||
| Total Asset | 9.41 M | ||||
| Retained Earnings | (38.97 M) | ||||
| Working Capital | 8.61 M | ||||
| Net Asset | 9.41 M |
About Autonomix Medical, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Autonomix Medical, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Autonomix Medical, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Autonomix Medical, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.